Coverage
-
November 05, 2021
New Jersey's chief federal judge on Friday agreed with health officials that policies by Sanofi-Aventis US LLC and Novo Nordisk Inc. run afoul of a federal drug discount program meant to benefit the poor, but regulators can't penalize the companies just yet.
2 other articles on this case.
View all »